Bath & Body Works, Inc. (BBWI) · Sep 23, 2026 · Other events
591,366-PSU CEO award — $40–$100 stock-price hurdles; vesting September 20, 2030
A large CEO equity grant links rewards to stock-price hurdles through 2030, with relative performance and continued service still gating payout.
Bath & Body Works is in the early execution phase of CEO Daniel Heaf’s multi-year “Consumer First Formula,” a turnaround focused on product innovation, brand relevance, and marketplace expansion. Recent 2026 updates say the company is making progress but still treating the transformation as work in progress.
This is an incentive-alignment filing, not a new operating catalyst. The company granted Heaf 591,366 performance share units at target, effective September 21, 2026. 〔0〕 The award pays out based on four-year stock-price hurdles of $40, $60, $80, and $100, corresponding to 75%, 100%, 150%, and 200% of target (Stock Price Hurdle). Because the filing contains no operating results, guidance change, or transaction, there is no clean beat-or-miss benchmark; versus the standing story, it mainly formalizes how Heaf will be rewarded for delivering the turnaround.
The structure is demanding but not purely stock-price driven. The award vests on September 20, 2030, assuming continued employment. 〔1〕 If Bath & Body Works ranks below the 55th percentile on relative total shareholder return, the earned award is cut by 50%. That makes the grant a stronger signal of long-term accountability than a simple retention award, while the 200% cap limits the maximum payout to 1,182,732 shares at target-level math (Stock Price Hurdle).
The economic significance is real but the informational surprise is limited. Heaf’s transformation mandate and executive-equity framework were already part of the company’s public setup; the new information is the exact size, hurdles, and vesting mechanics. The grant creates potential future dilution and concentrates attention on long-term stock performance, but it does not change current sales, margins, cash flow, or the turnaround plan itself.
Bottom line: This filing strengthens the link between Heaf’s compensation and a multi-year recovery, but it does not materially change the business story today. It is compensation architecture, not evidence that the transformation is succeeding or failing.
Q3 results, late November 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!